Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases

Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases is a phase 1 interventional study registered as NCT00858429 by Northwestern University, with 18 participants recorded, started 2009-04-01 and reaching its primary completion in 2014-03-19. Interventions recorded: capecitabine, yttrium Y 90 glass microspheres. Conditions recorded: Liver Cancer, Metastatic Cancer.

Linked to the drug Doxifluridine because the registry names it among its interventions and Hepatocellular carcinoma and Metastatic cancer among its conditions. Registry record only: no result has been read by an editor.